UniSuper Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
10,974
+1,467
| +15% | +$223K | 0.01% | 523 |
|
|
2025
Q1 | $1.43M | Sell |
9,507
-526
| -5% | -$79.2K | 0.01% | 534 |
|
|
2024
Q4 | $1.85M | Buy |
10,033
+1,724
| +21% | +$318K | 0.01% | 477 |
|
|
2024
Q3 | $1.64M | Buy |
8,309
+1,203
| +17% | +$237K | 0.01% | 506 |
|
|
2024
Q2 | $1.47M | Buy |
7,106
+3,103
| +78% | +$641K | 0.01% | 500 |
|
|
2024
Q1 | $1.08M | Buy |
4,003
+3,278
| +452% | +$888K | 0.01% | 492 |
|
|
2023
Q4 | $171K | Sell |
725
-73
| -9% | -$17.3K | ﹤0.01% | 557 |
|
|
2023
Q3 | $156K | Sell |
798
-116
| -13% | -$22.7K | ﹤0.01% | 509 |
|
|
2023
Q2 | $192K | Buy |
+914
| New | +$192K | ﹤0.01% | 480 |
|